Crossref journal-article
Oxford University Press (OUP)
Toxicological Sciences (286)
Bibliography

Olaharski, A. J., Bitter, H., Gonzaludo, N., Kondru, R., Goldstein, D. M., Zabka, T. S., Lin, H., Singer, T., & Kolaja, K. (2010). Modeling Bone Marrow Toxicity Using Kinase Structural Motifs and the Inhibition Profiles of Small Molecular Kinase Inhibitors. Toxicological Sciences, 118(1), 266–275.

Authors 9
  1. Andrew J. Olaharski (first)
  2. Hans Bitter (additional)
  3. Nina Gonzaludo (additional)
  4. Rama Kondru (additional)
  5. David M. Goldstein (additional)
  6. Tanja S. Zabka (additional)
  7. Henry Lin (additional)
  8. Thomas Singer (additional)
  9. Kyle Kolaja (additional)
References 48 Referenced 12
  1. 10.1016/j.exphem.2008.10.009 / Exp. Hematol. / A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis (2009)
  2. 10.1038/sj.leu.2404988 / Leukemia / Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation (2008)
  3. 10.1073/pnas.0805963106 / Proc. Natl. Acad. Sci. U.S.A. / LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation (2009)
  4. 10.1016/S0093-7754(01)90282-9 / Semin. Oncol. / Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance (2001)
  5. 10.1182/blood-2007-04-083808 / Blood / Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene (2008)
  6. 10.1016/j.gene.2006.07.009 / Gene / Isolation and molecular characterization of the porcine transforming growth factor beta type I receptor (TGFBR1) gene (2006)
  7. 10.1080/10428190310001641251 / Leuk. Lymphoma / Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma (2004)
  8. 10.1038/leu.2008.221 / Leukemia / Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase (2008)
  9. 10.1056/NEJMoa062867 / N. Engl. J. Med. / Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia (2006)
  10. {'key': 'key\n\t\t\t\t20170508165812_bib10', 'volume-title': 'Cluster Analysis', 'year': '2001', 'edition': '4th ed'} / Cluster Analysis (2001)
  11. 10.1038/nbt1068 / Nat. Biotechnol. / A small molecule-kinase interaction map for clinical kinase inhibitors (2005)
  12. 10.1111/j.1365-2184.2007.00438.x / Cell Prolif. / Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro (2007)
  13. 10.1189/jlb.0209097 / J. Leukoc. Biol. / MAPK signaling pathways in the regulation of hematopoiesis (2009)
  14. 10.1021/jm050736c / J. Med. Chem. / Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)ph enyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase (2006)
  15. {'key': 'key\n\t\t\t\t20170508165812_bib15', 'first-page': '679', 'article-title': 'A semi-mechanistic model of CP-690,550-induced reduction in neutrophil counts in patients with rheumatoid arthritis', 'volume': '50', 'year': '2009', 'journal-title': 'J. Clin. Pharmacol.'} / J. Clin. Pharmacol. / A semi-mechanistic model of CP-690,550-induced reduction in neutrophil counts in patients with rheumatoid arthritis (2009)
  16. {'key': 'key\n\t\t\t\t20170508165812_bib16', 'first-page': '3519', 'article-title': 'Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice', 'volume': '119', 'year': '2009', 'journal-title': 'J. Clin. Invest.'} / J. Clin. Invest. / Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice (2009)
  17. 10.3109/10428199609054832 / Leuk. Lymphoma / Role of hepatocyte growth factor in hemopoiesis (1996)
  18. 10.1182/blood.V97.7.1990 / Blood / Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice (2001)
  19. {'key': 'key\n\t\t\t\t20170508165812_bib19', 'volume-title': 'Finding Groups in Data: An Introduction to Cluster Analysis', 'year': '1990'} / Finding Groups in Data: An Introduction to Cluster Analysis (1990)
  20. 10.1016/j.bbrc.2007.05.206 / Biochem. Biophys. Res. Commun. / NEK7 is a centrosomal kinase critical for microtubule nucleation (2007)
  21. 10.1002/art.24567 / Arthritis Rheum. / The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo (2009)
  22. 10.1074/jbc.272.36.22679 / J. Biol. Chem. / LOK is a novel mouse STE20-like protein kinase that is expressed predominantly in lymphocytes (1997)
  23. 10.1182/blood-2005-08-3470 / Blood / A recombinant single-chain IL-7/HGFbeta hybrid cytokine induces juxtacrine interactions of the IL-7 and HGF (c-Met) receptors and stimulates the proliferation of CFU-S12, CLPs, and pre-pro-B cells (2006)
  24. 10.1126/science.1075762 / Science / The protein kinase complement of the human genome (2002)
  25. 10.1158/0008-5472.CAN-08-0634 / Cancer Res. / Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels (2008)
  26. 10.1001/jama.295.21.2516 / JAMA / Sunitinib in patients with metastatic renal cell carcinoma (2006)
  27. 10.1093/annonc/mdg250 / Ann. Oncol. / Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors (2003)
  28. 10.1182/blood-2006-05-023093 / Blood / Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors (2006)
  29. 10.1080/10428190802322919 / Leuk. Lymphoma / Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment (2008)
  30. 10.1371/journal.pcbi.1000446 / PLoS Comput. Biol. / Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors (2009)
  31. 10.1016/j.toxlet.2009.03.012 / Toxicol. Lett. / In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates (2009)
  32. 10.1128/MCB.01867-08 / Mol. Cell. Biol. / The Nek6 and Nek7 protein kinases are required for robust mitotic spindle formation and cytokinesis (2009)
  33. {'key': 'key\n\t\t\t\t20170508165812_bib33', 'first-page': '1131', 'article-title': 'Phase II study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post polycythemia vera/essential thrombocythemia myelofibrosis', 'volume': '115', 'year': '2009', 'journal-title': 'Blood'} / Blood / Phase II study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post polycythemia vera/essential thrombocythemia myelofibrosis (2009)
  34. 10.1002/cm.20039 / Cell Motil. Cytoskeleton / Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells (2004)
  35. 10.1016/S0022-2836(02)00857-4 / J. Mol. Biol. / Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450 (2002)
  36. 10.1172/JCI35636 / J. Clin. Invest. / The PKC inhibitor AEB071 may be a therapeutic option for psoriasis (2008)
  37. 10.1073/pnas.0602565103 / Proc. Natl. Acad. Sci. U.S.A. / Differential requirement for Lck during primary and memory CD8+ T cell responses (2006)
  38. 10.1146/annurev.cellbio.13.1.513 / Annu. Rev. Cell Dev. Biol. / Cellular functions regulated by Src family kinases (1997)
  39. {'key': 'key\n\t\t\t\t20170508165812_bib39', 'first-page': '1594', 'article-title': 'Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid restricted kinase, GRK6', 'volume': '115', 'year': '2009', 'journal-title': 'Blood'} / Blood / Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid restricted kinase, GRK6 (2009)
  40. 10.1359/jbmr.080409 / J. Bone Miner. Res. / PDGF receptor beta is a potent regulator of mesenchymal stromal cell function (2008)
  41. 10.1369/jhc.2009.954628 / J. Histochem. Cytochem. / Analysis of cell type-specific expression of CK1 epsilon in various tissues of young adult BALB/c Mice and in mammary tumors of SV40 T-Ag-transgenic mice (2010)
  42. 10.1016/S1359-6446(05)03477-X / Drug Discov. Today / Kinomics: characterizing the therapeutically validated kinase space (2005)
  43. {'key': 'key\n\t\t\t\t20170508165812_bib43', 'first-page': '885', 'article-title': 'Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+)', 'volume': '26', 'year': '1998', 'journal-title': 'Exp. Hematol.'} / Exp. Hematol. / Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+) (1998)
  44. 10.1007/s00277-008-0605-6 / Ann. Hematol. / Regulation of FLT3 and its ligand in normal hematopoietic progenitor cells (2009)
  45. 10.1007/s10528-009-9226-6 / Biochem. Genet. / Molecular cloning, expression, and chromosomal mapping of the porcine CDC-2-like kinase 1 (CLK1) gene (2009)
  46. 10.1016/j.febslet.2006.10.069 / FEBS Lett. / Nek7 kinase is enriched at the centrosome, and is required for proper spindle assembly and mitotic progression (2006)
  47. 10.1074/jbc.M412680200 / J. Biol. Chem. / Calmodulin and calmodulin-dependent kinase IIalpha regulate osteoblast differentiation by controlling c-fos expression (2005)
  48. 10.4161/cc.6.5.3921 / Cell cycle / p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure (2007)
Dates
Type When
Created 14 years, 11 months ago (Sept. 1, 2010, 9:44 p.m.)
Deposited 5 years, 2 months ago (June 11, 2020, 12:44 a.m.)
Indexed 2 years, 3 months ago (May 20, 2023, 9:32 a.m.)
Issued 15 years ago (Sept. 1, 2010)
Published 15 years ago (Sept. 1, 2010)
Published Online 15 years ago (Sept. 1, 2010)
Published Print 14 years, 10 months ago (Nov. 1, 2010)
Funders 0

None

@article{Olaharski_2010, title={Modeling Bone Marrow Toxicity Using Kinase Structural Motifs and the Inhibition Profiles of Small Molecular Kinase Inhibitors}, volume={118}, ISSN={1096-0929}, url={http://dx.doi.org/10.1093/toxsci/kfq258}, DOI={10.1093/toxsci/kfq258}, number={1}, journal={Toxicological Sciences}, publisher={Oxford University Press (OUP)}, author={Olaharski, Andrew J. and Bitter, Hans and Gonzaludo, Nina and Kondru, Rama and Goldstein, David M. and Zabka, Tanja S. and Lin, Henry and Singer, Thomas and Kolaja, Kyle}, year={2010}, month=sep, pages={266–275} }